. 2014 Oct 14;3(4):215–223. doi: 10.1530/EC-14-0100
This work is licensed under a Table 2.
Clinical characteristics of Group 2.
| Characteristic | PPI usersa (n=29) | Controls (n=50) | Combined (n=79) |
|---|---|---|---|
| Mean age (range) (years) | 60 (46–79) | 47.1 (28–75)* | 50.5 (28–79)† |
| Gender (M:F) | 11:18 | 23:27 | 34:45‡ |
| GI pathology (C:G:P) | 19:6:4 | – | – |
C, cyst; G, GERD; P, pancreatitis. *P<0.005 vs PPI (two-tailed Mann–Whitney U test); † P<0.03 vs NETs (two-tailed Mann–Whitney U test). ‡ χ 2=2.5, P=NS vs NETs (Fisher's exact test, two-tailed).
a
Treatment includes lansoprazole (60 mg, n=1), omeprazole (5 mg, n=2; 20 mg, n=4; and 40 mg, n=6), pantoprazole (40 mg, n=4 and 60 mg, n=1), and rabeprazole (20 mg, n=1).